Advertisement
Advertisement
PRQR
ProQR Therapeutics N.V. Ordinary Shares
1.49
USDSponsored
-0.32
-17.96%
Jun 25, 12:03 UTC -4
Open
PRQR Earnings Reports
Positive Surprise Ratio
PRQR beat 29 of 41 last estimates.
71%
Next Report
Date of Next Report
Aug 05, 2026
Estimate for Q2 26 (Revenue/ EPS)
$4.67M
/-$0.12
Implied change from Q1 26 (Revenue/ EPS)
+129.74%
/-7.69%
Implied change from Q2 25 (Revenue/ EPS)
+22.36%
/--
ProQR Therapeutics N.V. Ordinary Shares earnings per share and revenue
On May 12, 2026, PRQR reported earnings of -0.13 USD per share (EPS) for Q1 26, missing the estimate of -0.12 USD, resulting in a -6.56% surprise. Revenue reached 2.03 million, compared to an expected 5.35 million, with a -62.02% difference. The market reacted with a -0.62% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 6 analysts forecast an EPS of -0.12 USD, with revenue projected to reach 4.67 million USD, implying an decrease of -7.69% EPS, and increase of 129.74% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
enGene Therapeutics Inc. Common Stock
Report Date
Jun 15, 2026 For Q2 26
Estimate
-$0.47
Actual
-$0.43
Surprise
+10.32%
Grace Therapeutics, Inc. Common Stock
Report Date
Jun 18, 2026 For Q4 26
Estimate
-$0.23
Actual
-$0.06
Surprise
+74.42%
Vistagen Therapeutics, Inc. Common Stock
Report Date
Jun 15, 2026 For Q4 26
Estimate
-$0.34
Actual
-$0.37
Surprise
-7.75%
FAQ
What were ProQR Therapeutics N.V. Ordinary Shares's earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, ProQR Therapeutics N.V. Ordinary Shares reported EPS of -$0.13, missing estimates by -6.56%, and revenue of $2.03M, -62.02% below expectations.
How did the market react to ProQR Therapeutics N.V. Ordinary Shares's Q1 2026 earnings?
The stock price moved down -0.62%, changed from $1.61 before the earnings release to $1.60 the day after.
When is ProQR Therapeutics N.V. Ordinary Shares expected to report next?
The next earning report is scheduled for Aug 05, 2026.
What are the forecasts for ProQR Therapeutics N.V. Ordinary Shares's next earnings report?
Based on 6
analysts, ProQR Therapeutics N.V. Ordinary Shares is expected to report EPS of -$0.12 and revenue of $4.67M for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement